Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
01 Junio 2023 - 7:00AM
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical
company focused on developing and commercializing novel treatments
for gastrointestinal diseases, announced today that members of its
management team will participate in the following upcoming investor
conferences:
- 2023 Jefferies Healthcare Conference in New
York City, NY, with a scheduled fireside chat on Wednesday, June 7,
2023, at 1:30 p.m. EDT. Management will also participate in
one-on-one meetings throughout the conference, which runs from June
7-9, 2023.
- 44th Annual Goldman Sachs Global Healthcare
Conference in Dana Point, CA, with a scheduled fireside
chat on Wednesday, June 14, 2023, at 11:00 a.m. EDT. Management
will also participate in one-on-one meetings throughout the
conference, which runs from June 12-15, 2023.
To access the live webcast and archived recordings of the
fireside chats, visit the News & Events section of the Phathom
website at
https://investors.phathompharma.com/news-events/events-and-presentations.
The recordings will be available for 90 days following each
event.
About Phathom Pharmaceuticals, Inc.Phathom
Pharmaceuticals is a biopharmaceutical company focused on the
development and commercialization of novel treatments for
gastrointestinal diseases. Phathom has in-licensed the exclusive
rights in the United States, Europe, and Canada to vonoprazan, a
first-in-class potassium-competitive acid blocker (PCAB). For more
information about Phathom, visit the Company’s website
at www.phathompharma.com and follow the
Company on LinkedIn and Twitter.
MEDIA CONTACTNick
Benedetto1-877-742-8466media@phathompharma.com
INVESTOR CONTACTEric
Sciorilli1-877-742-8466ir@phathompharma.com
© 2023 Phathom Pharmaceuticals. All rights reserved.
Phathom Pharmaceuticals (NASDAQ:PHAT)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Phathom Pharmaceuticals (NASDAQ:PHAT)
Gráfica de Acción Histórica
De May 2023 a May 2024